Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert A Schnoll

Showing results (1-10 of 119) with videos related to

Pageof 12
Sort By:
Expert Opinion on Emerging Drugs|August 31, 2006
Current and emerging pharmacotherapies for treating tobacco dependenceRobert A Schnoll, Caryn Lerman
Drug and Alcohol Dependence|January 13, 2009
Sex heterogeneity in pharmacogenetic smoking cessation clinical trialsRobert A Schnoll, Freda Patterson
Journal of the National Cancer Institute|April 22, 2004
Tobacco control in the physician's office: a matter of adequate training and resourcesRobert A Schnoll, Paul F Engstrom
Biomarkers in Medicine|November 23, 2011
Biomarkers to optimize the treatment of nicotine dependenceRobert A Schnoll, Frank T Leone
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Impact of psychological distress on outcomes in cancer patientsCarolyn Y Fang, Robert A Schnoll
CNS Drugs|June 21, 2007
Pharmacogenetics and smoking cessation with nicotine replacement therapyRiju Ray, Robert A Schnoll, Caryn Lerman
Journal of Women'S Health (2002)|October 17, 2007
Treating tobacco dependence in womenRobert A Schnoll, Freda Patterson, Caryn Lerman
Annual Review of Medicine|July 28, 2009
Nicotine dependence: biology, behavior, and treatmentRiju Ray, Robert A Schnoll, Caryn Lerman
Journal of Addictive Diseases|March 14, 2013
Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patchRobert A Schnoll, Frank T Leone, Brian Hitsman
Addictive Behaviors|January 17, 2012
Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessationRobert A Schnoll, E Paul Wileyto, Caryn Lerman
Pageof 12

Showing results (1-10 of 119) with videos related to

Sort By:
Pageof 12
Expert Opinion on Emerging Drugs|August 31, 2006
Current and emerging pharmacotherapies for treating tobacco dependenceRobert A Schnoll, Caryn Lerman
Drug and Alcohol Dependence|January 13, 2009
Sex heterogeneity in pharmacogenetic smoking cessation clinical trialsRobert A Schnoll, Freda Patterson
Journal of the National Cancer Institute|April 22, 2004
Tobacco control in the physician's office: a matter of adequate training and resourcesRobert A Schnoll, Paul F Engstrom
Biomarkers in Medicine|November 23, 2011
Biomarkers to optimize the treatment of nicotine dependenceRobert A Schnoll, Frank T Leone
Expert Review of Pharmacoeconomics & Outcomes Research|October 8, 2009
Impact of psychological distress on outcomes in cancer patientsCarolyn Y Fang, Robert A Schnoll
CNS Drugs|June 21, 2007
Pharmacogenetics and smoking cessation with nicotine replacement therapyRiju Ray, Robert A Schnoll, Caryn Lerman
Journal of Women'S Health (2002)|October 17, 2007
Treating tobacco dependence in womenRobert A Schnoll, Freda Patterson, Caryn Lerman
Annual Review of Medicine|July 28, 2009
Nicotine dependence: biology, behavior, and treatmentRiju Ray, Robert A Schnoll, Caryn Lerman
Journal of Addictive Diseases|March 14, 2013
Symptoms of depression and smoking behaviors following treatment with transdermal nicotine patchRobert A Schnoll, Frank T Leone, Brian Hitsman
Addictive Behaviors|January 17, 2012
Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessationRobert A Schnoll, E Paul Wileyto, Caryn Lerman
Pageof 12